/PRNewswire/ Respiratory Diagnostics Market in terms of revenue was estimated to be worth $5.6 billion in 2023 and is poised to reach $8.2 billion by 2029,.
"In February 2023, Thermo Fisher Scientific Inc. (US) acquired TIB Molbiol (Germany), to expand its PCR test portfolio with a wide range of assays for infectious diseases."CT/NG Testing Market in terms of revenue was
/PRNewswire/ In the near future, the CT/NG (Chlamydia and Gonorrhea) testing industry is poised to witness significant advancements and transformations..
/PRNewswire/ The point of care molecular diagnostics industry is poised for significant growth and advancements in the near future. With the increasing.